DOCSLIB.ORG

AOGD Bulletin July 2018.Indd

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

AAOGDOGD Volume 18; Issue No.3; July 2018 BBULLETINULLETPrice:I ` 30N only AOGD Theme 2018-19 Issue: Current Update Empowering Providers: Viral Hepatitis in Pregnancy Enhancing Women’s Health Contraception AAOGDOGD SSECRETARIATECRETARIAT Department of Obstetrics and Gynecology Lady Hardinge Medical College & Smt. Sucheta Kriplani Hospital, New Delhi-110001 [email protected] Vol. 18, No.3; July, 2018 www.aogd.org 1 AOGD Offi ce-Bearers 2018-19 Dr Abha Singh Dr Manju Puri President Vice President Dr Reena Yadav Dr Kiran Aggarwal Scientifi c Advisor Hon. Secretary Dr Anuradha Singh Dr Nishtha Jaiswal Dr Prabha Lal Dr Shilpi Nain Joint Secretaries Treasurer Co Treasurer Editorial Board Dr Ratna Biswas Dr Manisha Kumar Editor Web Editor Dr Pikee Saxena Dr Sharda Patra Dr Swati Agrawal Dr Vidhi Chaudhary Co-Editors Co-Web Editor Dr Meenakshi Singh Dr Muntaha Dr Amrita Dr Aastha Shrivastava Dr Deepika Meena Dr Aishwarya Kapur Clinical Secretary Public Relations & Hospitality 2 AOGD Bulletin AOGD Executive Committee 2018-19 President Patrons Dr Abha Singh Dr S N Mukherjee Dr Urmil Sharma Vice President Dr Kamal Buckshee AOGD BULLETIN Dr Manju Puri Dr Neera Aggarwal Vol. 18, No.3; July, 2018 Scientifi c Advisor Advisors Dr Reena Yadav Dr Gauri Devi Dr Geeta Radhakrishnan Hony. Secretary Dr Reva Tripathi Contents Dr Kiran Aggarwal Dr S B Khanna Dr Sharda Jain BEST CLINICAL PRACTICE - Standards of Care: Hepatitis B 7 Treasurer Dr Usha Gupta Dr Prabha Lal in Pregnancy Ex Offi cio Ankur Jindal Editor Executive Past Presidents Dr Ratna Biswas Dr P Chadha (1990-94) RECENT ADVANCES - Hepatitis E Vaccination in Pregnancy 14 Dr Neera Agarwal (1994-97) Swati Sinha, Manoj Kumar Web Editor Dr Maya Sood (1997-99) Dr Manisha Kumar Dr D Takkar (1999-2001) CONTROVERSY - Management of Fulminant Hepatic 18 Dr Sudha Salhan (2001-03) Failure due to Hepatitis E in Pregnancy Joint Secretaries Dr Swaraj Batra (2003-05) Sharda Patra Dr Anuradha Singh Dr N B Vaid (2005-06) Dr Nishtha Jaiswal Dr S S Trivedi (2006-07) CASE APPROACH - Liver Transplantation in Acute Hepatitis 22 Co-Treasurer Dr Suneeta Mittal (2007-08) E Induced Fulminant Hepatic Failure in Pregnancy- A Dr I Ganguli (2008-09) Dr Shilpi Nain way forward Dr Shashi Prateek (2009-10) Piyush Kumar Sinha Co-Editors Dr U Manaktala (2010-11) Dr Pikee Saxena Dr Neerja Goel (2011-12) DISTRESS TO DE-STRESS - What are You Cooking …… Inside? 26 Dr Sharda Patra Dr C Raghunandan (2012-13) Mohit D Gupta Dr Swati Aggarwal Dr Alka Kriplani (2013-14) Dr U P Jha (2014-15) CROSSWORD - The Maze of Knowledge and Pictorial Quiz 28 Co-Web Editor Dr Pratima Mittal (2015-16) Swati Agrawal Dr Vidhi Chaudhary Dr Sudha Prasad (2016-17) Clinical Secretary Immediate Past President BEST CLINICAL PRACTICE - Standard of Care for Post 35 Dr Meenakshi Singh (2017-2018) Abortion and Post Partum Contraception Dr Shalini Rajaram Prabha Lal Public Relations & Hospitality Immediate Past Secretary Dr Muntaha (2017-2018) RECENT ADVANCES - Male Contraception 37 Dr Vidhi Chaudhary Dr Abha Sharma R.C.M. Kaza Dr Amrita Dr Aastha Shrivastava President Elect (2019-2020) CONTROVERSY - Contraception in Adolescent 47 Dr Deepika Meena Dr Neerja Batla Shakuntla Kumar Dr Aishwarya Kapur Vice President FOGSI CASE APPROACH - Contraception in Obese 54 Dr Pratima Mittal Executive Members Swati Agrawal, Nihita Pandey Dr Achala Batra Chairpersons Dr Amita Suneja AOGD Sub-Committees JOURNAL SCAN 58 Dr Anjali Tempe Dr Susheela Gupta Ratna Biswas Dr B K Goyal Dr Surveen Ghumman Dr Dinesh Kansal Dr Abha Sharma Proceedings of AOGD Monthly Clinical Meeting 61 Dr Indu Chawla Dr A G Radhika Dr J B Sharma Dr Amita Jain Dr Kanwal Gujral Dr Shakuntla Kumar Dr Manju Khemani Dr Ashok Kumar Dr Malavika Sabharwal Dr Vatsla Dadhwal Dr Nirmala Aggarwal Dr Rupinder Sekhon Dr Ranjana Sharma Dr Anjali Tempe Disclaimer Dr Renu Misra Dr Renu Misra The advertisements in this bulletin are not a warranty, endorsement or approval of Dr Sadhna Gupta Dr Nalini Mahajan the products or services. The statements and opinions contained in the articles of Dr Sangeeta Gupta the AOGD Bulletin are solely those of the individual authors and contributors, and Dr S N Basu do not necessarily refl ect the opinions or recommendations of the publisher. The Dr Suman Lata publisher disclaims responsibility of any injury to persons or property resulting from Dr Vijay Kadam any ideas or products referred to in the articles or advertisements. Plagiarism Disclaimer Any plagiarism in the articles will be the sole responsibility of the authors, the editorial board or publisher will not be responsible for this. Publisher/Printer/Editor Dr Ratna Biswas on behalf of Association of Obstetricians & Gynecologists of Delhi. Printed at Process & Spot C-112/3, Naraina Industrial Area, Phase-1, New Delhi 110 028 Published from Department of Obstetrics and Gynecology Lady Hardinge Medical College & Smt. Sucheta Kriplani Hospital, New Delhi - 110001 AOGD Secretariat Editor Department of Obstetrics and Gynecology Dr Ratna Biswas Lady Hardinge Medical College & Smt. Sucheta Kriplani Hospital, New Delhi 110001 Ph. No. 011-23408297; Email: [email protected] Tel No: 011-23408297; Email: [email protected] www.aogd.org Total number of pages = 64 Vol. 18, No.3; July, 2018 3 PPresident’sresident’s MMessageessage Dear Friends, Monsoon Greetings! It is indeed my privilege to be able to reach out to all AOGD members each month through the AOGD bulletin. Last month marked the celebration of the International Yoga Day on 21st June 2018. The AOGD members actively participated in the International Yoga Day organised at Rajpath. Public awareness forum was conducted for antenatal women on 20th June to emphasize the importance of yoga for the pregnant mother and her developing fetus. Trained Ayush instructors demonstrated asanas suitable for pregnant women in the antenatal OPD of Smt Sucheta Kriplani Hospital. Another important occasion was “Doctors Day” on 1st of July. The event was marked by planting of trees at Panchsheel Park by more than 100 enthusiastic members of FOGSI and AOGD. The slogan given by President FOGSI for the year was “Plant a tree.” The Clinical meeting was also organised by R&R Hospital on 29th June. We are committed to the theme of AOGD, “To empower providers to enhance women’s health”. Empowerment of Health care professionals requires sustained efforts from all of us. I hope you have found the contents of the journal informative. CME are also organized in this regard from time to time. World Population Day falls on 11th July so, this month’s issue of the AOGD Bulletin deals with “Contraception”. Another important day this month is the World Hepatitis Day on 28th July so this issue will also cover “Viral Hepatitis in Pregnancy”. I urge the members to organize contraception awareness programs for public and doctors. The Annual Conference is slated for 24th & 25th November with preconference workshops and we assure you a great scientifi c bonanza with wide coverage of all key areas in Obstetrics and Gynecology. Please block the dates for this most important event of the year. We hope the AOGD members will attend and participate in the Annual Conference in large numbers and also encourage their fellow colleagues and friends to become AOGD members to strengthen this organization. I would like you to encourage your PGs and friends to become member of this association. We have an active website www.aogd.org where you can fi nd all new announcements and glimpse of the past activities. We welcome any suggestions and comments which you may mail us at [email protected] Best wishes and happy reading . Dr Abha Singh President AOGD (2018-19) 4 AOGD Bulletin SSecretary’secretary’s MMessageessage Greetings from AOGD offi ce, The weather was hot and humid in the preceding month but the spirits were soaring and we had a lot of activity going on at our end. The AOGD members were also active and did various projects. Endometriosis committee of AOGD had a successful CME on 10th July with a Sunday houseful of delegates and faculty. Breast and cervical screening camps were also organised. A very successful public forum titled “Importance of Yoga” was held in Smt Sucheta Kriplani hospital. It was heartening to note the zeal with which the pregnant women wanted to learn about simple yoga exercises to improve the pregnancy outcome. It was indeed a magnifi cent experience to celebrate the “International day of Yoga” with thousands at Rajpath. Doctor’s day celebrations were done along with the clinical meeting at Army hospital R-R and also with tree plantation by enthusiastic members of FOGSI &AOGD. The Editorial team has brought out a comprehensive and well planned bulletin. It is indeed encouraging to receive request from number of members who want to participate in academic activities and we will try to involve as many members as we can in the forthcoming events. Save your dates for the Annual conference on 24-25th November 2018 at India Habitat Centre. We are trying to reach you and inform you about all the events through website aogd.org, emails and sms’s. If the information is not reaching you please communicate on the following mail [email protected]. Enjoy the monsoon Dr Kiran Aggarwal Secretary AOGD (2018-19) Monthly Clinical Meeting Monthly Clinical Meet will be held at All India Institute of Medical Science, New Delhi on Friday, 27th July, 2018 from 04:00pm to 05:00pm. Vol. 18, No.3; July, 2018 5 EEditorialditorial Team’sTeam’s MessageMessage Dr Ratna Biswas Dr Pikee Saxena Dr Sharda Patra Dr Swati Agrawal Editor Co-Editors Dear Friends, This month we celebrate the World Population Day on 11th July and World Hepatitis Day on 28th July, hence this month’s Update is on Contraception and Viral Hepatitis in Pregnancy.
Recommended publications
  • Sterilization and Abortion Policy Billing Instructions

    Sterilization and Abortion Policy Billing Instructions

    Sterilization and Abortion Policy Billing Instructions Table of contents Table of contents ...................................................................................................................................... 1 Hysterectomy ............................................................................................................................................ 2 Acknowledgement forms ..................................................................................................................... 2 Prior authorization requirements ......................................................................................................... 2 Covered services ................................................................................................................................... 2 Intrauterine Devices and Subdermal Implants ......................................................................................... 4 Family planning: sterilization .................................................................................................................... 4 Prior authorization requirements ......................................................................................................... 5 Covered services ................................................................................................................................... 5 Abortion .................................................................................................................................................... 6 Claim
  • U.S. Medical Eligibility Criteria for Contraceptive Use, 2016

    U.S. Medical Eligibility Criteria for Contraceptive Use, 2016

    Morbidity and Mortality Weekly Report Recommendations and Reports / Vol. 65 / No. 3 July 29, 2016 U.S. Medical Eligibility Criteria for Contraceptive Use, 2016 U.S. Department of Health and Human Services Centers for Disease Control and Prevention Recommendations and Reports CONTENTS Introduction ............................................................................................................1 Methods ....................................................................................................................2 How to Use This Document ...............................................................................3 Keeping Guidance Up to Date ..........................................................................5 References ................................................................................................................8 Abbreviations and Acronyms ............................................................................9 Appendix A: Summary of Changes from U.S. Medical Eligibility Criteria for Contraceptive Use, 2010 ...........................................................................10 Appendix B: Classifications for Intrauterine Devices ............................. 18 Appendix C: Classifications for Progestin-Only Contraceptives ........ 35 Appendix D: Classifications for Combined Hormonal Contraceptives .... 55 Appendix E: Classifications for Barrier Methods ..................................... 81 Appendix F: Classifications for Fertility Awareness–Based Methods ..... 88 Appendix G: Lactational
  • Patient Instructions for Post-Vasectomy Fertility Test: Semen Specimen Collection

    Patient Instructions for Post-Vasectomy Fertility Test: Semen Specimen Collection

    Patient Instructions for Post-Vasectomy Fertility Test: Semen Specimen Collection Semen specimen 12 weeks after your vasectomy: Twelve weeks (3 months) after your vasectomy, you should collect a semen specimen in the container provided to you by the Urology Department. It is recommended that you have at least 20 ejaculations within the 12-week period after your vasectomy. Depending on the results of your initial sample, you may be asked by your physician to provide another sample. You must utilize an alternate method of contraception until cleared by your physician. You are considered fertile following vasectomy until, as per the American Urological Assn. recommendations, at least one semen analysis shows no fertile sperm. On rare occasions, the vasectomy can fail and the vas deferens tubes can rejoin. Your semen specimen can be brought by yourself to the Urology Clinic only if: It can be in the laboratory within one hour of collection, and It is kept at room temperature during that time. It is suggested, however, that you create your semen specimen while you are at the Urology Clinic. Your semen specimen deposit should be scheduled in advance by Kathy Stevens: call 434-924-9548 or 434- 924-9560. Please note the following important instructions and guidelines for semen collection: The sample should be collected after a minimum of 2 days, and a maximum of 7 days, of sexual abstinence. If you choose to collect the specimen at home, it must be collected in a clean specimen container with a secure lid, such as one with a screw-on cap.
  • Opinion Study on Vasectomy, Sterilized Version of Male Keywords: Vasectomy; Contraception; Sperm; Gonads Contraception

    Opinion Study on Vasectomy, Sterilized Version of Male Keywords: Vasectomy; Contraception; Sperm; Gonads Contraception

    Opinion iMedPub Journals Journal of Contraceptive Studies 2017 http://www.imedpub.com ISSN 2471- 9749 Vol. 2 No. 1:5 DOI: 10.21767/2471-9749.100028 Opinion study on Vasectomy, Sterilized Audrey Kanes Version of Male Contraception Department of Endocrinology, Universidad de São Paulo, Brazil Abstract Corresponding author: Audrey Kanes Vasectomy, it is well known heard around the world as the extreme perfect [email protected] sterilized process of contraception which is known to be synonym of contraception for males, male animals too. Amid vasectomy, a medicinal services supplier closes Professor, Department of Endocrinology, or obstructs the tubes that convey sperm. At the point when the tubes are shut, Universidad de São Paulo, Brazil. sperm can't leave a man's body and cause pregnancy. Sperms are made in the Gonads will go through two tubes called the vasa differentia to different organs Tel: +55 19 3521-7000 and blend with original liquids to frame semen. Vasectomy obstructs every vas deferens and keeps sperm out of the original liquid. Sperms are consumed by the body as opposed to being discharged. Without your thickened sperm (discharge) can't bring the suspect chance on pregnancy. Citation: Kanes A. Opinion study on Vasectomy, Sterilized Version of Male Keywords: Vasectomy; Contraception; Sperm; Gonads Contraception. J Contracept Stud. 2017, 2:1 Received: March 02, 2017, Accepted: March 09, 2017 Published: March 16, 2017 Sterilized Procedure There are diverse routes for men to be cleaned. One write does not require an entry point - a cut. Alternate sorts of vasectomy require an entry point. Cut strategies take around 20 min [1-3].
  • Sterilization As a Family Planning Method

    Sterilization As a Family Planning Method

    December 2018 | Fact Sheet Sterilization as a Family Planning Method Sterilization is a permanent method of contraception, and is the most commonly used form of family planning among couples both in the United States and worldwide. For men and women who no longer want to have children, sterilization offers a permanent, safe, cost-effective and efficacious way to prevent unintended pregnancy. Male sterilization is less common than female sterilization, but both are nearly 100% effective at preventing pregnancy. The Affordable Care Act’s no-cost coverage of sterilization has increased the affordability of the procedure for women, but it is still unclear the overall effect this will have on future utilization rates. Recent changes to insurance coverage policy, broader availability of long- acting contraceptives, as well as changes in the health care delivery system may reshape the choices that men and women make regarding the use of sterilization as a contraceptive method. This fact sheet explains the types of sterilization procedures available to women and men, reviews private insurance and Medicaid coverage policy, and discusses issues that affect availability in the U.S. Female Sterilization Female sterilization is an Figure 1 outpatient surgical Prevalence of Sterilization Among Women 15 to 44 Who procedure. The procedure Report Using a Reversible or Permanent Contraceptive blocks the fallopian tubes, Method, 2013-2015, by Selected Characteristics preventing eggs from All women, ages 15-44 22% travelling down the tubes to the uterus and blocking Ages 25-34 19% sperm from fertilizing the Ages 35-44 39% egg. Data from the Centers for Disease Control and Black 26% Hispanic 25% Prevention (CDC) show that White 21% among women ages 15 to 44 who use a contraceptive ≥ 200% FPL 16% method, one in five used ≤ 200% FPL 29% tubal ligation as their method 1 of contraception.
  • Family Planning, Sterilization and Abortion Services

    Family Planning, Sterilization and Abortion Services

    bmchp.org | 888-566-0008 wellsense.org | 877-957-1300 Reimbursement Policy Family Planning, Sterilization and Abortion Services Policy Number: 4.115 Version Number: 9 Version Effective Date: 07/01/2017 Product Applicability All Plan+ Products Well Sense Health Plan Boston Medical Center HealthNet Plan New Hampshire Medicaid MassHealth NH Health Protection Program Qualified Health Plans/ConnectorCare/Employer Choice Direct Senior Care Options Note: Disclaimer and audit information is located at the end of this document. Policy Summary The Plan reimburses covered family planning, sterilization and abortion items and services based on the provider’s contractual rates with the Plan and the terms of reimbursement identified within this policy. For information specific to genetic testing please reference the medical policies: Genetic Testing Guidelines and Pharmacogenetics, OCA 3.727, and Preimplantation Genetic Testing (Preimplantation Genetic Diagnosis and Pregenetic Testing), OCA 3.726. Prior-Authorization Please refer to the Plan’s Prior Authorization Requirements Matrix at www.bmchp.org. + Plan refers to Boston Medical Center Health Plan, Inc. and its affiliates and subsidiaries offering health coverage plans to enrolled members. The Plan operates in Massachusetts under the trade name Boston Medical Center HealthNet Plan and in other states under the trade name Well Sense Health Plan. 1 of 8 Provider Reimbursement Abortion Services The Plan provides coverage for abortion services. Payment for an abortion service represents full compensation for these services, including the preoperative evaluation and counseling, laboratory and radiology services, surgery, and postoperative care. Family Planning Services The Plan will reimburse for medical services, laboratory services and drugs related to family planning services when provided to an eligible member in a facility licensed as a clinic or a hospital and under the supervision of a physician.
  • A Novel Male Contraceptive Pill-Patch Combination: Oral Desogestrel and Transdermal Testosterone in the Suppression of Spermatogenesis in Normal Men

    A Novel Male Contraceptive Pill-Patch Combination: Oral Desogestrel and Transdermal Testosterone in the Suppression of Spermatogenesis in Normal Men

    0013-7227/01/$03.00/0 The Journal of Clinical Endocrinology & Metabolism 86(11):5201–5209 Printed in U.S.A. Copyright © 2001 by The Endocrine Society A Novel Male Contraceptive Pill-Patch Combination: Oral Desogestrel and Transdermal Testosterone in the Suppression of Spermatogenesis in Normal Men W. MORTON HAIR, KAY KITTERIDGE, DARYL B. O’CONNOR, AND FREDERICK C. W. WU Department of Endocrinology, Manchester Royal Infirmary, University of Manchester, Manchester, United Kingdom Downloaded from https://academic.oup.com/jcem/article/86/11/5201/2849291 by guest on 29 September 2021 M13 9WL This study investigated the effect of transdermal T and oral a dose of 75 ␮g was ineffective (0% azoospermic). Total and desogestrel on the reproductive axis of healthy men. Twenty- free plasma T were reduced by approximately 30%. High den- three men were randomized to 1 of 3 treatment groups and sity lipoprotein cholesterol was significantly reduced. No se- received a daily transdermal T patch plus oral desogestrel at rious side-effects were encountered. We conclude that daily a dose of 75, 150, or 300 ␮g/d for 24 wk. Baseline blood and self-administered desogestrel with transdermal T is capable semen samples were obtained and then every 4 wk thereafter of suppressing the male reproductive axis, although the effi- for 32 wk. The outcome measures were sperm density and cacy was less marked and less consistent than injectable reg- plasma levels of FSH, LH, total and free T. The results show a imens. The lower efficacy is likely to be due to failure of the dose-dependent suppression of spermatogenesis and gonad- transdermal T system to maintain circulating T levels consis- otropins.
  • Explaining Contraception Job Aids English

    Explaining Contraception Job Aids English

    Explaining Contraception Job Aids for Healthcare Providers This resource was developed by Cardea, www.cardeaservices.org Expert review of this resource was provided by Dr. Christine Dehlendorf from the University of California, San Francisco. Funding for this resource was made possible by the Office of Population Affairs (Grant FPT-PA006028-01-00). The views expressed do not necessarily reflect the official policies of the Department of Health and Human Services; nor does men- tion of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. Explaining Contraception — Job Aids July 2017 Table of Contents Introduction 1 Explaining Contraception — Job Aids 3 Long Acting Methods Little or nothing for the user to do or remember, following initiation of the method with a provider. Sterilization Female sterilization .......................................................................3 Male sterilization .........................................................................5 Long-acting reversible methods Intrauterine Devices (IUDs) ...............................................................7 Implant .................................................................................9 User Controlled Hormonal Methods Require the user to do something related to the method daily/weekly/monthly/every 3 months. Require a prescription. Injectable (shot) ...........................................................................11 Pills ......................................................................................13
  • Failure of Male Contraception: an Insight Siuli Mitra* and Gautam Kumar Kshatriya Department of Anthropology, University of Delhi, Delhi, India

    Failure of Male Contraception: an Insight Siuli Mitra* and Gautam Kumar Kshatriya Department of Anthropology, University of Delhi, Delhi, India

    hropolo nt gy A Mitra and Kshatriya, Anthropol 2014, 2:2 Anthropology DOI: 10.4172/2332-0915.1000119 ISSN: 2332-0915 CommentaryResearch Article OpenOpen Access Access Failure of Male Contraception: An Insight Siuli Mitra* and Gautam Kumar Kshatriya Department of Anthropology, University of Delhi, Delhi, India Introduction Before the revolution brought about by OCPs contraceptive options were limited to withdrawal, periodic abstinence and/or condoms [5]. Contraception is the answer to the surmounting pressure Subsequent development of Intra-uterine devices (IUDs) and tubal on ecology and economy caused by rapid population growth. surgical sterilization shifted the focus on women. After the latter gained Contraception is decreasing fertility in humans to prevent conception popularity the males gradually felt unimportant participating in a of an offspring. Conceiving and bearing a child is among the most service that is female-targeted. Eventually females became the clientele significant aspects of human existence. But limitations of a human body of family planning programmes and contraceptive methods available to conceive too many offspring and socio-economic factors constrain for women outnumbered those for males. Assumptions like men want having too many children in human societies. That is how the idea of more children, do not want to share responsibility of child rearing contraception was realized and different modes of contraception were and averse to contraception, have made them less preferred targets of devised to be directed at both males and females. However female family planning programmes. But recent surveys have denounced this contraception continues to be the more popular choice among couples attitude in men and shown that men are showing increased interest in in all human societies.
  • Comparing Effectiveness of Methods

    Comparing Effectiveness of Methods

    Com paring effectiveness of methods More effective Less than 1 pregnancy per 100 women in one year Implant IUD Female Vasectomy Sterilization UC Davis Obstetrics and Gynecology Appointments: (916) 734-6900 Injection – Lactational Pills Patch Vaginal For more information, visit our Depo-Provera Ring Amenorrhea website: https://health.ucdavis.edu/obgyn/ser vices/fp/ Even when people use birth control, they sometimes get pregnant when they don’t want to be. If that happens, your options would be to continue the Male Diaphragm pregnancy to parent a child, continue Female Fertility-Awareness the pregnancy and make an adoption Condoms Condoms Based Methods plan, or to have an abortion to end the pregnancy. Withdrawal Spermicide Less effective About 30 pregnancies per Adapted from WHO, 2007 100 women in one year Use of no contraception: about 85 pregnancies per 100 women in one year More Information about birth control methods available at UC Davis What is it? How Do I Get It? How Do I Use It? What Are the Advantages? What are the Disadvantages? STERILIZATION METHODS – Permanent. Last for the rest of your life Female or male Procedure which blocks or removes the Get It: A doctor performs a brief surgical Permanent methods mean you never have to worry You cannot change your mind and decide to get (vasectomy) woman’s fallopian tubes or a man’s vas procedure about birth control again pregnant later sterilization deferens eliminating sperm/ovum transfer Use It: Vasectomy requires a test to make sure Short-term pain or discomfort after procedure
  • Myths and Fallacies About Male Contraceptive Methods

    Myths and Fallacies About Male Contraceptive Methods

    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by eCommons@AKU eCommons@AKU Community Health Sciences Department of Community Health Sciences March 2013 Myths and fallacies about male contraceptive methods: a qualitative study amongst married youth in slums of Karachi, Pakistan Noureen Aleem Nishtar Aga Khan University Neelofar Sami Anum Faruqi Aga Khan University Shaneela Khowaja Aga Khan University Farid Ul-Hasnain Aga Khan University Follow this and additional works at: https://ecommons.aku.edu/pakistan_fhs_mc_chs_chs Recommended Citation Nishtar, N. A., Sami, N., Faruqi, A., Khowaja, S., Ul-Hasnain, F. (2013). Myths and fallacies about male contraceptive methods: a qualitative study amongst married youth in slums of Karachi, Pakistan. Global Journal of Health Science, 5(2), 84-93. Available at: https://ecommons.aku.edu/pakistan_fhs_mc_chs_chs/520 Global Journal of Health Science; Vol. 5, No. 2; 2013 ISSN 1916-9736 E-ISSN 1916-9744 Published by Canadian Center of Science and Education Myths and Fallacies about Male Contraceptive Methods: A Qualitative Study amongst Married Youth in Slums of Karachi, Pakistan Noureen Nishtar1, Neelofar Sami2, Anum Faruqi3, Shaneela Khowaja4 & Farid-Ul-Hasnain5 1 Health Systems Division, Aga Khan University, Karachi, Pakistan 2 Willows Foundation, Pakistan 3 Family Medicine Department, Aga Khan University, Karachi, Pakistan 4 School of Nursing, Aga Khan University, Karachi, Pakistan 5 Reproductive Health Division, Aga Khan University, Karachi, Pakistan Correspondence: Dr. Noureen Aleem Nishtar, Research Fellow, Community Health Sciences Department. Aga Khan University, Karachi, Pakistan Received: November 12, 2012 Accepted: November 25, 2012 Online Published: December 4, 2012 doi:10.5539/gjhs.v5n2p84 URL: http://dx.doi.org/10.5539/gjhs.v5n2p84 Abstract Pakistan presently has one of the largest cohorts of young people in its history, with around 36 million people between the ages of 15 and 24 years.
  • Research in Reproduction : the Indian Scenario in the Last Decade

    Research in Reproduction : the Indian Scenario in the Last Decade

    Indian J Physiol Ph~rmacol 2001; 45 (I): 7-21 REVIEW ARTICLE RESEARCH IN REPRODUCTION: THE INDIAN SCENARIO IN THE LAST DECADE [II]* JAYASREE SENGUPTA Department of Physiology, All India Institute o.f Medical Sciences, New Delhi - 110 029 (Received OD August 10, 2000 ) Abstract: Developing new, improved and totally safe, effective and acceptable contraceptives based on the recent advances in cellular and molecular biology of reproduction is a new challenge to biomedical scientists involved in research in reproductive biology. The present article reviews some of the major contributions made during the last decade by scientists working in lndia in developing new strategies and technologies for better human reproductive health and fertility regulation. Key words: antHmplantation contraception fertility regulation hormonal antagonists hormonal contraceptives immuno-contraception natural contraceptives reproductive health INTRODUCTION to unprotected sexual intercourse and which will decrease the resort to abortion; In a UNICEF report it has been expanded male contraceptive choices, stated, "Family planning could bring more participation and responsibility (3). Now the benefits to more people than any other challenge for scientists in the related single technology now available to the areas is to translate this concept into human race" (1). The necessity of developing developing new, improved and totally safe, a strategy for woman centred agenda effective and acceptable contraceptives had been highlighted at the Cairo b~sed on the recent advances